Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
General Internal Medicine
•
Neurology
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
Related Questions
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
If a patient who has previously been taking lamotrigine stops taking it for between two weeks and a month, do you have to uptitrate it all over again or do you have another way to resume it?
What is your approach to weaning phenobarbital and serial EEGs in patients with HIE after their perinatal seizures are under control?
How do you manage follow-up lab findings of hyperchloremic metabolic acidosis and low bicarbonate in patients on zonisamide or topiramate?
How significant are the cardiovascular side effects, such as hypertension, associated with valproate?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
How do you utilize at-home seizure monitoring devices for your patients with epilepsy?
When would you start antiseizure medications in tuberous sclerosis before onset of seizures?
What are your preferred anti-seizure medications in Doose syndrome?
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
